Literature DB >> 919350

Cleavage maps of human adenovirus type 7 DNA by restriction endonuclease HindIII and EcoRI.

K Sekikawa, K Fujinaga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 919350     DOI: 10.1016/0042-6822(77)90022-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  Mappings of adenovirus type 7 cytoplasmic RNA species synthesized early in lytically infected cells and synthesized in transformed cells.

Authors:  K Yoshida; K Sekikawa; K Fujinaga
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

2.  Comparative sequence analysis of the inverted terminal repetitions from different adenoviruses.

Authors:  M Shinagawa; R Padmanabhan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

3.  Comparison of DNA sequences required for the function of citrate utilization among different citrate utilization plasmids.

Authors:  M Shinagawa; S Makino; T Hirato; N Ishiguro; G Sato
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

4.  Unique species of mRNA from adenovirus type 7 early region 1 in cells transformed by adenovirus type 7 DNA fragment.

Authors:  K Yoshida; K Fujinaga
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

5.  Biochemical studies on bovine adenovirus type 3. III. Cleavage maps of viral DNA by restriction endoncleases EcoRI, BamHI, and HindIII.

Authors:  T Kurokawa; K Igarashi; Y Sugino
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

6.  Transforming DNA sequences in rat cells transformed by DNA fragments of highly oncogenic human adenovirus type 12.

Authors:  Y Sawada; S Ojima; H Shimojo; K Shiroki; K Fujinaga
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Transformation of primary rat kidney cells by DNA fragments of weakly oncogenic adenoviruses.

Authors:  R Dijkema; B M Dekker; M J van der Feltz; A J van der Eb
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.